Examination Report |
1 | Additional Representation Sheet | 15 Mar 2011 |
1 | TM-1 | 15 Mar 2011 |
10 | Forwarding Letter for TM-5 | 16 Aug 2012 |
11 | Authorization Document (POA) | 29 Oct 2012 |
11 | TM-6 | 29 Oct 2012 |
12 | Authorization Document (POA) | 29 Oct 2012 |
12 | TM-6 | 29 Oct 2012 |
13 | Order | 08 Apr 2013 |
14 | Forwarding Letter for TM-6 | 29 Oct 2013 |
15 | Order | 07 Apr 2017 |
16 | Certificate | 10 Aug 2017 |
2 | Additional Representation Sheet | 15 Mar 2011 |
2 | TM-1 | 15 Mar 2011 |
3 | Power of Attorney | 15 Mar 2011 |
4 | TM-16 | 25 Nov 2011 |
5 | Authorization Document (POA) | 25 Nov 2011 |
5 | TM-16 | 25 Nov 2011 |
6 | Incorpration Certificate | 25 Nov 2011 |
6 | TM-16 | 25 Nov 2011 |
7 | Authorization Document (POA) | 25 Nov 2011 |
7 | Incorpration Certificate | 25 Nov 2011 |
8 | Journal Copy | 02 Jul 2012 |
9 | TM-5 | 31 Jul 2012 |
1 | Rule 50 Issue | 4058196 | 03 Oct 2016 | |
2 | Rule 50 Issue | 4058214 | 03 Oct 2016 | |
3 | General Order | 4679223 | 03 Apr 2017 | |
4 | O3 NOTICE | 10915924 | 5083577 | 05 Jan 2021 |
The application for Anzavir was made on 15 March 2011.
The trademark applicant for Anzavir is MYLAN LABORATORIES.
Anzavir is applied in class(es) 5.
Application for Anzavir is on Registered stage.
Application Id allotted to Anzavir is 2115420.
Trademark agent or attorney for the application is Wadia Ghandy & Co.
Anzavir filed with the Intellectual property office as a WORD.